207 related articles for article (PubMed ID: 18176688)
1. Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
Al-Khuwaitir TS; Al-Zuhair AA; Al-Ghamdi AG; Khan A
Saudi Med J; 2008 Jan; 29(1):129-32. PubMed ID: 18176688
[TBL] [Abstract][Full Text] [Related]
2. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Crump JA; Barrett TJ; Nelson JT; Angulo FJ
Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
Kadhiravan T; Wig N; Kapil A; Kabra SK; Renuka K; Misra A
BMC Infect Dis; 2005 May; 5():37. PubMed ID: 15904505
[TBL] [Abstract][Full Text] [Related]
5. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Rupali P; Abraham OC; Jesudason MV; John TJ; Zachariah A; Sivaram S; Mathai D
Diagn Microbiol Infect Dis; 2004 May; 49(1):1-3. PubMed ID: 15135492
[TBL] [Abstract][Full Text] [Related]
6. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Asna SM; Haq JA; Rahman MM
Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
[No Abstract] [Full Text] [Related]
7. Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Nkemngu NJ; Asonganyi ED; Njunda AL
BMC Infect Dis; 2005 Jun; 5():49. PubMed ID: 15969764
[TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotype Typhi.
Kim DM; Neupane GP; Jang SJ; Kim SH; Lee BK
Int J Antimicrob Agents; 2010 Aug; 36(2):155-8. PubMed ID: 20478696
[TBL] [Abstract][Full Text] [Related]
9. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
10. Early small bowel perforation and cochleovestibular impairment as rare complications of typhoid fever.
van Wolfswinkel ME; Lahri H; Wismans PJ; Petit PL; van Genderen PJ
Travel Med Infect Dis; 2009 Sep; 7(5):265-8. PubMed ID: 19747660
[TBL] [Abstract][Full Text] [Related]
11. Enteric fever treatment failures: a global concern.
Chandel DS; Chaudhry R
Emerg Infect Dis; 2001; 7(4):762-3. PubMed ID: 11585550
[No Abstract] [Full Text] [Related]
12. Typhoid fever: narrowing therapeutic options in India.
Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Bandyopadhyay R; Balaji V; Yadav B; Jasmine S; Sathyendra S; Rupali P
Trop Doct; 2018 Jul; 48(3):182-188. PubMed ID: 29495943
[TBL] [Abstract][Full Text] [Related]
14. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
15. Quinolone resistant enteric fever--problems and remedies.
Rodrigues C; Mehta A; Joshi VR
J Assoc Physicians India; 1998 Aug; 46(8):751-2. PubMed ID: 11229301
[No Abstract] [Full Text] [Related]
16. [What does it mean 'sensitive'? Failing ciprofloxacin in typhus abdominalis].
van 't Wout JW; Jones JO; Visser LG; Bijlmer HA; Veldkamp PJ; van Dissel JT
Ned Tijdschr Geneeskd; 2009 May; 153(19):914-8. PubMed ID: 19489296
[No Abstract] [Full Text] [Related]
17. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003.
Maskey AP; Basnyat B; Thwaites GE; Campbell JI; Farrar JJ; Zimmerman MD
Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):91-5. PubMed ID: 18023462
[TBL] [Abstract][Full Text] [Related]
18. [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
Akin K; Yavuzdemir S; Cesur S; Levent B; Esen B; Willke A
Mikrobiyol Bul; 2005 Jan; 39(1):83-7. PubMed ID: 15900841
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance in Salmonella Typhi.
Cooke FJ; Wain J; Threlfall EJ
BMJ; 2006 Aug; 333(7563):353-4. PubMed ID: 16902221
[No Abstract] [Full Text] [Related]
20. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Gupta V; Kaur J; Kaistha N
Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
